Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Helicobacter|November 28, 2015
Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies for Helicobacter pylori Strains Containing the gyrA MutationHideki Mori, Hidekazu Suzuki, Juntaro Matsuzaki, et al.
BMC Cancer|August 5, 2023
Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G)Naoki Takahashi, Hiroki Hara, Kengo Nagashima, et al.
United European Gastroenterology Journal|July 13, 2016
Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot studyHideki Mori, Hidekazu Suzuki, Juntaro Matsuzaki, et al.
Nature Medicine|January 6, 2026
Real-world clinical utility of comprehensive genomic profiling in advanced solid tumorsYuki Saito, Sara Horie, Yasunori Kogure, et al.
International Cancer Conference Journal|July 8, 2025
A rare case of ALK-positive histiocytosis with neurological involvement in a 70-year-old woman successfully managed with partial resection and alectinibEiichiro So, Norihito Ishida, Akihiko Chida, et al.
Investigational New Drugs|March 25, 2018
Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously treated with gemcitabine: a meta-analysisAkiyoshi Kasuga, Yasuo Hamamoto, Ayano Takeuchi, et al.
Future Oncology (London, England)|April 21, 2021
Analysis of risk factors for immune-related adverse events in various solid tumors using real-world dataKeitaro Shimozaki, Yasutaka Sukawa, Yasunori Sato, et al.
Esophagus : Official Journal of the Japan Esophageal Society|February 18, 2025
Investigating the synergistic effects of immunochemotherapy in esophageal squamous cell carcinomaJun Okui, Kengo Nagashima, Satoru Matsuda, et al.
International Journal of Clinical Oncology|February 17, 2025
Clinical utility of comprehensive genomic profiling for advanced pancreatic cancer: insights from real-world data analysisEiichiro So, Hideyuki Hayashi, Keitaro Shimozaki, et al.
Scientific Reports|October 9, 2021
Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumorsKeitaro Shimozaki, Hideyuki Hayashi, Shigeki Tanishima, et al.
Pageof 8